Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy

Circulation Research

Volumn 106, Issue 3, 2010, Pages 573-582

  Chandar, Suchitra ^a   Yeo, Li Sze ^a   Leimena, Christiana ^a   Tan, Ju Chiat ^b   Xiao, Xiao Hui ^b   Nikolova Krstevski, Vesna ^a   Yasuoka, Yoshinori ^a   Gardiner Garden, Margaret ^c   Wu, Jianxin ^a   Kesteven, Scott ^b   Karlsdotter, Lina ^a   Natarajan, Shweta ^a   Carlton, Arthur ^d   Rainer, Stephen ^e   Feneley, Michael P ^b,f,g   Fatkin, Diane ^a,b,g  

^a Molecular Cardiology Division   (Australia)

^b VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d Synapse Technology Pty Ltd   (Australia)

^e Division of Anatomical Pathology   (Australia)

^f ST VINCENT S HOSPITAL   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Carvedilol; Exercise; Familial dilated cardiomyopathy; Lamin A C; Mechanical stress

Indexed keywords

CARVEDILOL; DESMIN; LAMIN A; LAMIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; APOPTOSIS; ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DISEASE SEVERITY; EXERCISE; FEMALE; GENE MUTATION; GENETIC CODE; GENOTYPE; HEART VENTRICLE CONTRACTION; HETEROZYGOTE; HYPOOSMOTIC STRESS; MALE; MECHANICAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; THORACIC AORTA; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AORTA, THORACIC; APOPTOSIS; CARBAZOLES; CARDIOMYOPATHY, DILATED; CONSTRICTION; DESMIN; FEMALE; GENOTYPE; HEART; LAMIN TYPE A; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; OSMOTIC PRESSURE; PHYSICAL CONDITIONING, ANIMAL; PROPANOLAMINES; STRESS, MECHANICAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 77649166919     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.204388     Document Type: Article

References (35)

1. Fatkin D, Otway R, Richmond Z. Genetics of dilated cardiomyopathy. Heart Fail Clin. In press.
2. Fatkin D, MacRae C, Sasaki T, Wolff MR, Porcu M, Frenneaux M, Atherton J, Vidaillet HJ, Spudich S, De Girolami U, Seidman JG, Seidman CE. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715-1724.
3. Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S, Peterson A, Li D, Jakobs P, Litt M, Porter CB, Rahko PS, Hershberger RE. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J. 2008;156:161-169.
4. Taylor MRG, Fain PR, Sinagra G, Robinson ML, Robertson AD, Carniel E, Di Lenarda A, Bohlmeyer TJ, Ferguson DA, Brodsky GL, Boucek MM, Lascor J, Moss AC, Li WLP, Stetler GL, Muntoni F, Bristow MR, Mestroni L. Natural history of dilated cardiomyopathy due to lamin A/C gene mutations. J Am Coll Cardiol. 2003;4:771-780.
5. Pasotti M, Klersy C, Pilotto A, Marziliano N, Rapezzi C, Serio A, Mannarino S, Gambarin F, Favalli V, Grasso M, Agozzino M, Campana C, Gavazzi A, Febo O, Marini M, Landolina M, Mortara A, Piccolo G, Vigano M, Tavazzi L, Arbustini E. Long-term outcome and risk stratification in dilated cardio-laminopathies. J Am Coll Cardiol. 2008;52:1250-1260.
6. Sullivan T, Escalante-Alcade D, Bhatt H, Anver M, Bhat N, Nagashima K, Stewart CL, Burke B. Loss of A-type lamin expression compromises nuclear envelope integrity leading to muscular dystrophy. J Cell Biol. 1999;147:913-919.
7. Nikolova V, Leimena C, McMahon AC, Tan JC, Chandar S, Jogia D, Kesteven S, Michalicek J, Otway R, Verheyen F, Rainer S, Stewart CL, Martin D, Feneley MP, Fatkin D. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. J Clin Invest. 2004;113:357-369.
8. Wolf CM, Wang L, Alcalai R, Pizard A, Burgon PG, Ahmad F, Sherwood M, Branco DM, Wakimoto H, Fishman GI, See V, Stewart CL, Conner DA, Berul CI, Seidman CE, Seidman JG. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. J Mol Cell Cardiol. 2008;44:293-303.
9. Lammerding J, Schulze PC, Takahashi T, Kozlov S, Sullivan T, Kamm RD, Stewart CL, Lee RT. Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. J Clin Invest. 2004;113:370-378.
10. Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee RT. Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem. 2006;35:25768-25780.
11. Hutchison CJ, Alvarez-Reyes M, Vaughan OA. Lamins in disease: why do ubiquitously expressed nuclear envelope proteins give rise to tissue-specific disease phenotypes? J Cell Sci. 2001;114:9-19.
12. Burke B, Stewart CL. Life at the edge: the nuclear envelope and human disease. Nat Rev Mol Cell Biol. 2002;3:575-585.
13. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP. Tumor necrosis factor-a mediates cardiac remodelling and ventricular dysfunction after pressure overload state. Circulation. 2007;115:1398-1407.
14. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355. (Pubitemid 26152713)
15. Fernando P, Bonen A, Hoffman-Goetz L. Predicting submaximal oxygen consumption during treadmill running in mice. Can J Physiol Pharmacol. 1993;71:854-857.
16. Nakamura A, Yoshida K, Takeda S, Dohi N, Ikeda S. Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise in hearts of mdx mice. FEBS Lett. 2002;520:18-24.
17. Nishio R, Shioi T, Sasayama S, Matsumori A. Carvedilol increases the production of interleukin-12 and interferon-y and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol. 2003;41:340-345.
18. Suleymanian MA, Baumgarten CM. Osmotic gradient-induced water permeation across the sarcolemma of rabbit ventricular myocytes. J Gen Physiol. 1996;107:503-514.
19. Seul M, O'Gorman L, Sammon M. Analysis of point patterns. In: Seul M, O'Gorman L, Sammon M, eds. Practical Algorithms for Image Analysis. Cambridge, United Kingdom: Cambridge University Press; 2000:221-245.
20. 2-adrenergic receptors in the heart. Cardiovasc Res. 2000;48: 448-454.
21. Roos KP. Length, width, and volume changes in osmotically stressed myocytes. Am J Physiol Heart Circ Physiol. 1986;251:H1373-H1378.
22. Wang Y. Mitogen-activated protein kinases in heart development and diseases. Circulation. 2007;116:1413-1423.
23. Muchir A, Pavlidis P, Decostre V, Herron AJ, Arimura T, Bonne G, Worman HJ. Activation of MAPK pathways links LMNA mutations to cardiomyopathy in Emery-Dreifuss muscular dystrophy. J Clin Invest. 2007;117:1282-1293.
24. Arimura T, Helbling-Leclerc A, Massart C, Varnous S, Niel F, Lacene E, Fromes Y, Toussaint M, Mura AM, Keller DI, Amthor H, Isnard R, Malissen M, Schwartz K, Bonne G Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies. Hum Mol Genet. 2005;14:155-169.
25. Mounkes LC, Kozlov SV, Rottman JN, Stewart CL. Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. Hum Mol Genet. 2005;14:2167-2180.
26. Wang Y, Herron AJ, Worman HJ. Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy. Hum Mol Genet. 2006;15:2479-2489.
27. Konhilas JP, Leinwand LA. The effects of biological sex and diet on the development of heart failure. Circulation. 2007;116:2747-2759.
28. Warren DT, Zhang Q, Weissberg PL, Shanahan CM. Nesprins: intra-cellular scaffolds that maintain cell architecture and coordinate cell function? Expert Rev Mol Med. 2005;7:1-14.
29. Lee JSH, Hale CM, Panorchan P, Khatau SB, George JP, Tseng Y, Stewart CL, Hodzic D, Wirtz D. Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. Biophys J. 2007; 93:2542-2552.
30. Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, Fletcher BJ, Fleg JL, Myers JN, Sullivan MJ. Exercise and heart failure. A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation. 2003;107: 1210-1225.
31. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol. 1999;31:2063-2076.
32. Han R, Bansal D, Miyake K, Muniz VP, Weiss RM, McNeill PL, Campbell KP. Dysferlin-mediated membrane repair protects the heart from stress-induced left ventricular injury. J Clin Invest. 2007;117: 1805-1813.
33. Cheng J, Kamiya K, Kodama I. Carvedilol: molecular and cellular basis for its multifaceted therapeutic potential. Cardiovasc Drug Rev. 2001;19: 152-171.
34. Caron M, Auclair M, Donadille B, et al. Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ. 2007;14:1759-1767.
35. Charniot JC, Bonnefont-Rousselot D, Marchand C, Zerhouni K, Vignat N, Peynet J, Plotkine M, Legrand A, Artigou JY. Oxidative stress implication in a new phenotype of amyotrophic quadricipital syndrome with cardiac involvement due to lamin A/C mutation. Free Radic Res. 2007;41:424-431.